he global Biomarkers Market Size is expected to reach US$ 137.7 billion by 2027 and is expected to grow at an impressive double-digit rate of 14.1% from 2020 to 2027.
The study includes drivers and restraints of this market. The study provides an analysis of the global Biomarkers Market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2020 is considered as the base year.
Why should you invest in this report?
If you are aiming to enter the global Biomarkers Market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for Biomarkers are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Download the Sample Pages for More Understanding@ https://www.precedenceresearch.com/sample/1182
Growth Factors
Factors such as high incidence of cancer, increasing focus on establishment of biomarker-based diagnostic methods, and growing number of contract research organizations are driving the growth of biomarkers market. The high incidence of chronic ailments, rapidly expanding applications of biomarkers in diagnostics, high funding for research and development in biopharmaceutical companies, increasing research and development activities in developing regions, and string product pipeline are further propelling the biomarkers market expansion across the globe. According to the World Health Organization, from the year 2010 to 2022, the United States is expected to observe high volume of new cancer cases and is anticipated to rise around 24% in males to more than 1 million cancer cases per year, and by around 21% in females to more than 900,000 cancer cases per year. In 2018, there were around 18 million cancer cases globally. Lung and breast cancers stood at the top position in cancer types worldwide, individually contributing 12.3% of the total cancer cases diagnosed in the year 2018.
Moreover, the constantly rising cases of chronic ailments such as cardiovascular disorders, diabetes, COPD, and asthma are contributing to the increased demand for biomarkers-based diagnostic approaches. As per the World Health Organization, cardiovascular disorders are the topmost cause of death worldwide. The WHO data further reveals that, four out of five cardiovascular disorder related deaths are because of stroke and heart attack.
Report Highlights
- Among the type segment, safety biomarkers dominated the overall market. Increasing use of biomarkers in the drug development as well as drug discovery domains is the major reason for high market share of safety biomarkers.
- Among the diseases, cancer accounted for the largest revenue with more than 32% share in 2019. High cancer incidence worldwide and increasing demand for early detection is the major reasons for high market share of cancer. Neurological disorders are expected to grow at the topmost CAGR during the forecast time-frame. Increasing focus on development of biomarker-based diagnostic methods for the detection of neurological conditions is the major reason for the high growth.
- Drug Discovery accounted for the largest revenue in the application segment. Use of biomarkers in the pre-clinical trials and increasing investment in research and development is the key reason for high market share of drug discovery.
- F. Hoffmann-La Roche Ltd. accounted for a significant share of the global biomarkers market.
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1182
Key Market Players and Strategies
- Bio-Rad Laboratories, Inc.
- Qiagen
- Epigenomics AG
- Abbott
- Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Johnson & Johnson Services, Inc.
- Abbott
- Siemens
- Thermo Fisher Scientific, Inc.
Major Market Segments Covered:
By Type
- Validation
- Efficacy
- Safety
By Disease
- Neurological Diseases
- Cancer
- Immunological Diseases
- Cardiovascular Diseases
- Others
By Application
- Personalized Medicines
- Drug Discovery & Development
- Diagnostics
- Others
Regional Analysis:
The geographical analysis of the global Biomarkers Market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American market is again segmented into the US, Canada, and Mexico. Coming to the European market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global Biomarkers Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global Biomarkers Market in 2027?
- What is the expected CAGR for the Biomarkers Market between 2020 and 2027?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global Biomarkers Market?
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1182
About Us:
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
About Precedence Research
0 comments :
Post a Comment